122 related articles for article (PubMed ID: 17516864)
1. Retinol inhibits the invasion of retinoic acid-resistant colon cancer cells in vitro and decreases matrix metalloproteinase mRNA, protein, and activity levels.
Park EY; Wilder ET; Lane MA
Nutr Cancer; 2007; 57(1):66-77. PubMed ID: 17516864
[TBL] [Abstract][Full Text] [Related]
2. Retinol inhibits the growth of all-trans-retinoic acid-sensitive and all-trans-retinoic acid-resistant colon cancer cells through a retinoic acid receptor-independent mechanism.
Park EY; Dillard A; Williams EA; Wilder ET; Pepper MR; Lane MA
Cancer Res; 2005 Nov; 65(21):9923-33. PubMed ID: 16267017
[TBL] [Abstract][Full Text] [Related]
3. Retinol decreases beta-catenin protein levels in retinoic acid-resistant colon cancer cell lines.
Dillard AC; Lane MA
Mol Carcinog; 2007 Apr; 46(4):315-29. PubMed ID: 17219422
[TBL] [Abstract][Full Text] [Related]
4. Retinol decreases phosphatidylinositol 3-kinase activity in colon cancer cells.
Park EY; Wilder ET; Chipuk JE; Lane MA
Mol Carcinog; 2008 Apr; 47(4):264-74. PubMed ID: 17918208
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
[TBL] [Abstract][Full Text] [Related]
6. 1 alpha, 25-dihydroxyvitamin D3 and all-trans-retinoic acid inhibit the growth of a lung cancer cell line.
Higashimoto Y; Ohata M; Nishio K; Iwamoto Y; Fujimoto H; Uetani K; Suruda T; Nakamura Y; Funasako M; Saijo N
Anticancer Res; 1996; 16(5A):2653-9. PubMed ID: 8917365
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of inhibition on activator protein-1 activity by all-trans retinoic acid in gastric cancer cells.
Wu Q; Chen Z; Su W
Chin Med J (Engl); 2000 Nov; 113(11):972-6. PubMed ID: 11776129
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
[TBL] [Abstract][Full Text] [Related]
9. Retinol Increases beta-catenin-RXRalpha binding leading to the increased proteasomal degradation of beta-catenin and RXRalpha.
Dillard AC; Lane MA
Nutr Cancer; 2008; 60(1):97-108. PubMed ID: 18444141
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid receptor beta 2 mRNA is elevated by retinoic acid in vivo in susceptible regions of mid-gestation mouse embryos.
Harnish DC; Jiang H; Soprano KJ; Kochhar DM; Soprano DR
Dev Dyn; 1992 Jul; 194(3):239-46. PubMed ID: 1334737
[TBL] [Abstract][Full Text] [Related]
11. Retinol and retinoic acid increase MMP-2 activity by different pathways in cultured Sertoli cells.
Dalmolin RJ; Zanotto-Filho A; De Oliveira RB; Duarte RF; Pasquali MA; Moreira JC
Free Radic Res; 2007 Dec; 41(12):1338-47. PubMed ID: 18075836
[TBL] [Abstract][Full Text] [Related]
12. Expression and regulation of retinoic acid receptors in human breast cancer cells.
Roman SD; Clarke CL; Hall RE; Alexander IE; Sutherland RL
Cancer Res; 1992 Apr; 52(8):2236-42. PubMed ID: 1313739
[TBL] [Abstract][Full Text] [Related]
13. Expression of epithelial markers and retinoid-binding proteins in retinol- or retinoic acid-treated intestinal cells in vitro.
Plateroti M; Sambuy Y; Nobili F; Bises G; Perozzi G
Exp Cell Res; 1993 Sep; 208(1):137-47. PubMed ID: 8395395
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
Wan H; Dawson MI; Hong WK; Lotan R
Oncogene; 1997 Oct; 15(17):2109-18. PubMed ID: 9366527
[TBL] [Abstract][Full Text] [Related]
15. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
Kumar A; Soprano DR; Parekh HK
Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
[TBL] [Abstract][Full Text] [Related]
16. Silencing and re-expression of retinoic acid receptor beta2 in human melanoma.
Fan J; Eastham L; Varney ME; Hall A; Adkins NL; Chetel L; Sollars VE; Georgel P; Niles RM
Pigment Cell Melanoma Res; 2010 Jun; 23(3):419-29. PubMed ID: 20374520
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of gamma-tocotrienol on invasion and metastasis of human gastric adenocarcinoma SGC-7901 cells.
Liu HK; Wang Q; Li Y; Sun WG; Liu JR; Yang YM; Xu WL; Sun XR; Chen BQ
J Nutr Biochem; 2010 Mar; 21(3):206-13. PubMed ID: 19195866
[TBL] [Abstract][Full Text] [Related]
18. The DNA-binding epidermal growth factor-receptor inhibitor PD153035 and other DNA-intercalating cytotoxic drugs reactivate the expression of the retinoic acid receptor-beta tumor-suppressor gene in breast cancer cells.
Grunt TW; Tomek K; Wagner R; Puckmair K; Zielinski CC
Differentiation; 2007 Nov; 75(9):883-90. PubMed ID: 17608728
[TBL] [Abstract][Full Text] [Related]
19. Effects of retinoic acid and gamma-interferon on expression of retinoic acid receptor and cellular retinoic acid-binding protein in breast cancer cells.
Widschwendter M; Daxenbichler G; Dapunt O; Marth C
Cancer Res; 1995 May; 55(10):2135-9. PubMed ID: 7743514
[TBL] [Abstract][Full Text] [Related]
20. All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo.
Leville CD; Dassow MS; Seabrook GR; Jean-Claude JM; Towne JB; Cambria RA
J Surg Res; 2000 May; 90(2):183-90. PubMed ID: 10792961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]